Detail
Article
Online article
FT
Medvik - BMC
  • Something wrong with this record ?

Erythropoetiny v terapii z pohledu farmaceutického chemika
[Erythropoetins in therapy from the point of view of a medicinal chemist]

Oldřich Farsa, Peter Zubáč

. 2019 ; 113 (9) : 540-544.

Status minimal Language Czech Country Czech Republic

Hematopoietic growth factors are cytokines which stimulate growth of hematopoietic pluripotent stem cells and their differentiation and maturation into fully function-al blood cells, either erythrocytes or various types of white blood cells. Erythropoietin is a glycosylated peptide hor-mone which stimulates production of red blood cells. It is used for treatment of anaemia caused by a chronic kidney failure. For therapeutic purposes, it is produced by recom-binant technologies predominantly using modified mam-malian cells. This procedure leads, however, to peptides of the same sequence of 165 amino acids but with different glycosylation patterns. These different mixtures of erythro-poietin glycoforms have been designated with different INN names epoetin alfa – omega. Peginesatid (Omontys®) is a synthetic erythropoietin receptor agonist, the structure of which does not match that of erythropoietin. It is a pegylated covalent dimer of two identical peptide chains. It has been abandoned due to an increased mortality from cardiovascular reasons and due to dangerous allergies.

Erythropoetins in therapy from the point of view of a medicinal chemist

Bibliography, etc.

Literatura

000      
00000naa a2200000 a 4500
001      
bmc19039267
003      
CZ-PrNML
005      
20231123094239.0
007      
ta
008      
191107s2019 xr a f 000 0|cze||
009      
AR
040    __
$a ABA008 $d ABA008 $e AACR2 $b cze
041    0_
$a cze $b eng
044    __
$a xr
100    1_
$a Farsa, Oldřich, $d 1971- $7 mzk2005279207 $u Ústav chemických léčiv, Farmaceutická fakulta, Veterinární a farmaceutická univerzita Brno, Palackého 1946/1, 612 42 Brno
245    10
$a Erythropoetiny v terapii z pohledu farmaceutického chemika / $c Oldřich Farsa, Peter Zubáč
246    31
$a Erythropoetins in therapy from the point of view of a medicinal chemist
504    __
$a Literatura
520    9_
$a Hematopoietic growth factors are cytokines which stimulate growth of hematopoietic pluripotent stem cells and their differentiation and maturation into fully function-al blood cells, either erythrocytes or various types of white blood cells. Erythropoietin is a glycosylated peptide hor-mone which stimulates production of red blood cells. It is used for treatment of anaemia caused by a chronic kidney failure. For therapeutic purposes, it is produced by recom-binant technologies predominantly using modified mam-malian cells. This procedure leads, however, to peptides of the same sequence of 165 amino acids but with different glycosylation patterns. These different mixtures of erythro-poietin glycoforms have been designated with different INN names epoetin alfa – omega. Peginesatid (Omontys®) is a synthetic erythropoietin receptor agonist, the structure of which does not match that of erythropoietin. It is a pegylated covalent dimer of two identical peptide chains. It has been abandoned due to an increased mortality from cardiovascular reasons and due to dangerous allergies.
700    1_
$a Zubáč, Peter $7 xx0310546 $u Ústav chemických léčiv, Farmaceutická fakulta, Veterinární a farmaceutická univerzita Brno, Palackého 1946/1, 612 42 Brno
773    0_
$t Chemické listy $x 0009-2770 $g Roč. 113, č. 9 (2019), s. 540-544 $w MED00011010
856    41
$u http://www.chemicke-listy.cz/ojs3/index.php/chemicke-listy/article/view/3451/3402 $y domovská stránka časopisu
910    __
$a ABA008 $b B 1918 $c 395 $y 0 $z 0
990    __
$a 20191107060734 $b ABA008
991    __
$a 20231123094234 $b ABA008
999    __
$a min $b bmc $g 1462406 $s 1077855
BAS    __
$a 3
BMC    __
$a 2019 $b 113 $c 9 $d 540-544 $i 0009-2770 $m Chemické listy $n Chem. Listy $x MED00011010
LZP    __
$a NLK 2019-50/vt

Find record

Citation metrics

Loading data ...

Archiving options

Loading data ...